Nuzenio

Jiangsu Hengrui Pharmaceuticals

Jiangsu Hengrui Pharmaceuticals news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Hengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets - MoomooMoomoo · Mon, 10 Aug 2026 03:17:35 GMTBraveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 12:27:37 GMTHengrui Eyes Fresh NDA For Mounjaro Rival After Second Phase III Diabetes Win - insights.citeline.cominsights.citeline.com · Wed, 05 Aug 2026 08:11:52 GMTHengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials - MoomooMoomoo · Wed, 05 Aug 2026 03:25:12 GMTEditorial: How China is outpacing the US in R&D and innovation - Chemical & Engineering NewsChemical & Engineering News · Wed, 29 Jul 2026 13:32:04 GMTHow 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce PharmaFierce Pharma · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 03:17:35 GMTHengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets - Moomoo
Thu, 06 Aug 2026 12:27:37 GMTBraveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui - Fierce Biotech
Wed, 05 Aug 2026 08:11:52 GMTHengrui Eyes Fresh NDA For Mounjaro Rival After Second Phase III Diabetes Win - insights.citeline.com
Wed, 05 Aug 2026 03:25:12 GMTHengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials - Moomoo
Wed, 29 Jul 2026 13:32:04 GMTEditorial: How China is outpacing the US in R&D and innovation - Chemical & Engineering News
Tue, 28 Jul 2026 07:00:00 GMTHow 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce Pharma

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Jiangsu Hengrui Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.